Supernus Pharmaceuticals is a specialty pharmaceutical company specific expertise in developing differentiated products in collaboration with partners and for its own CNS product portfolio.
Among the company's key technologies are ProScreen® and OptiScreen® for lead selection and formulation optimization, Microtrol®, Solutrol® and EnSoTrol®, its oral controlled release technologies, and AvertSM, its reduced abuse potential technology. Supernus will focus on developing differentiated products for targeted specialty therapeutic areas on its own and in partnership with other pharmaceutical companies.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
Head office
Supernus Pharmaceuticals Inc.
1550 E. Gude Drive
Rockville
Maryland
20850 Maryland
All rights reserved. Terms and Conditions | Contact us
